Atezolizumab Stumbles in Triple Negative Breast Cancer Study: SABCS 2024 Results with Charles Geyer
Similar Tracks
ctDNA: SABCS 2024 - ZEST Trial Cleans Up - Niraparib vs. Placebo in High-Risk Breast Cancer Patients
OncologyTube
Dr Bartlett, Lecturer of Exercise Immunology, discusses exercise and nutrition for CLL patients.
CLL Support Association (CLLSA)
Sight + Sound Bites: Keratoconus: Current and Future Advancements in Treatment
Eye & Ear Foundation of Pittsburgh